HomeNewsBusinessman With Chronic Fatigue Sues NHS Over Medical Care

Businessman With Chronic Fatigue Sues NHS Over Medical Care

A businessman who says he developed chronic fatigue after receiving the hepatitis B vaccine is suing the NHS for more than £1 million.

Wayne Bloore, 53, was running an IT company and six Subway restaurants when a doctor advised him to have the hepatitis B vaccination in 2008.

He received three doses, but claims aluminium hydroxide used in the vaccine triggered chronic fatigue syndrome (CFS) and myalgic encephalomyelitis (ME), leaving him unable to continue working as before.

Mr Bloore previously worked as many as 16 hours a day. He has since had to give up his businesses and says he now spends up to 20 hours a day resting. His symptoms also include difficulty concentrating, muscle pain and blurred vision.

Giving evidence, Mr Bloore stressed that he is “not anti-vaccine at all”, but maintains that the hepatitis B jab caused his illness. He is seeking more than £1 million in damages from Doncaster and Bassetlaw Teaching Hospitals at the High Court in London.

The NHS Trust accepts that Mr Bloore was not given adequate information about the vaccine’s possible side-effects.

However, it disputes his claim that CFS and ME were among those risks and is contesting the compensation case.

The court heard that Mr Bloore received his first dose of GlaxoSmithKline’s Engerix-B vaccine in 2008, followed by further doses in 2010 and 2014.

Wayne Bloore claims the hepatitis B vaccine gave him chronic fatigue syndrome and is now suing the NHS for more than £1million

Wayne Bloore says the hepatitis B vaccine caused his chronic fatigue syndrome and is seeking more than £1 million from the NHS

Doncaster and Bassetlaw Teaching Hospitals could face paying damages at the High Court

Doncaster and Bassetlaw Teaching Hospitals is defending the damages claim at the High Court

Mr Bloore says he began feeling unwell in 2010, experiencing abdominal pain, recurring exhaustion and migraines. His fatigue fluctuated over the following years, according to his account.

After receiving the booster in 2014, however, he says the fatigue became “near constant”. He was diagnosed with CFS and ME the following year.

In written submissions, his barrister Harry Lambert said Mr Bloore had been left with a permanent and disabling condition characterised by “fatigue, muscle pain and weakness”.

“The claimant has to pace himself,” Mr Lambert said. “He tries to do as much as he can on good days but often ‘pays’ for it in the days which follow.

“When muscle ache or fatigue is particularly bad, he is effectively housebound or severely restricted in what he can do until his energy levels recover.

“This can be debilitating, with the claimant needing to spend more than 20 hours a day resting.

“He also suffers from cognitive difficulties, including reduced concentration, impaired information processing and problems with decision-making, multitasking and finding words. He has blurred vision and mental fatigue.”

Mr Lambert said his client had been forced to leave his position at a software company in 2010 or 2011 and that his condition was now permanent.

The barrister said the core of Mr Bloore’s case was that aluminium hydroxide, which is added to vaccines to stimulate an immune response, directly caused his CFS and ME.

He told the court that a doctor had identified macrophagic myofasciitis (MMF), a lesion at the injection site involving chronic inflammation and excess aluminium salts.

“It is hypothesised that MMF lesions are a marker of an inability to efficiently clear aluminium hydroxide adjuvant from immune cells following vaccination,” he told Judge Sylvia De Bertodano.

“It is the claimant’s case that the [hepatitis B vaccine] resulted in MMF, as demonstrated by the July 2016 biopsy, with associated ME/CFS.”

Mr Lambert argued that Mr Bloore should succeed if the vaccine was found to have played any role in the onset of his illness.

“If the vaccine was the proximate cause, the claimant succeeds,” he said. “If it was the final straw that broke the camel’s back, then again the claimant succeeds.

“We are not saying the vaccine is unsafe or that anybody should hesitate to have it. On a population level, it is a great vaccine.”

His argument, he said, was that the vaccine had an exceptionally rare effect on Mr Bloore, who was predisposed to developing CFS and ME.

The court heard that Mr Bloore’s legal action is based partly on the allegation that he was not properly warned about possible side-effects and would have declined the vaccinations had he been given suitable information.

The NHS accepts that an adequate warning was not provided, but argues there is no compelling evidence that the hepatitis B vaccine can cause CFS or ME.

Alexander Hutton KC, representing the NHS Trust, said Mr Bloore’s medical history did not establish “a persuasive case of a temporal connection between dose and illness”.

“The burden of proof lies on the claimant to prove his case on medical causation on the balance of probabilities, namely that it was one or more doses of the HB vaccine that caused or materially contributed to his contracting CFS/ME and/or at the very least exacerbating existing CFS/ME,” he told the judge.

“It is contended that the expert evidence will show that the aetiology — that is, the specific cause — of CFS/ME is, at best, only partially understood by medical science. There are a number of theories and only some partial hard evidence on the question.

“In all the expert reports, it appears to be common ground that there is not one single paper providing a systematic study of a possible causal link between CFS/ME and hepatitis B vaccination.”

Mr Hutton said Mr Bloore had conducted his own internet research and become convinced that the vaccine was responsible. He argued that part of the claim relied on “purely anecdotal vague second-hand evidence” of a connection between the vaccination and his condition.

He added: “The claimant’s case is that he has suffered a side-effect of the Engerix-B vaccine, namely CFS/ME — a condition which is at best only partially understood scientifically — which was not then and is not now a recognised side-effect listed in the drug company’s patient leaflet, even among the very rare side-effects occurring in one in 10,000 cases that must be recorded.

“He does so with, as is common ground, no randomised controlled trial or epidemiological studies demonstrating the cause and effect he seeks to prove.

“It is contended that, in all the circumstances, the claimant has come nowhere close to proving on the balance of probabilities that the hepatitis B vaccines caused, materially contributed to or exacerbated his CFS/ME. Notwithstanding the court will undoubtedly have considerable sympathy for him, this is a claim that should be dismissed.”

The hearing is ongoing.